Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.